Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,699Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9SALIX

02 24SALIX PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHYLNALTREXONE BROMIDE

US Patent Number : 8420663

Drug Substance Claim :

Drug Product Claim :

Application Number : 21964

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2029-09-30

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHYLNALTREXONE BROMIDE

US Patent Number : 8420663

Drug Substance Claim :

Drug Product Claim :

Application Number : 21964

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2029-09-30

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHYLNALTREXONE BROMIDE

US Patent Number : 8420663

Drug Substance Claim :

Drug Product Claim :

Application Number : 21964

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2029-09-30

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHYLNALTREXONE BROMIDE

US Patent Number : 8822490

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21964

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2029-09-30

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHYLNALTREXONE BROMIDE

US Patent Number : 8822490

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21964

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2029-09-30

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHYLNALTREXONE BROMIDE

US Patent Number : 9180125

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21964

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2029-09-30

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHYLNALTREXONE BROMIDE

US Patent Number : 9180125

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21964

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2029-09-30

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHYLNALTREXONE BROMIDE

US Patent Number : 9180125

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21964

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2029-09-30

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHYLNALTREXONE BROMIDE

US Patent Number : 9180125

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208271

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2029-09-30

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

METHYLNALTREXONE BROMIDE

US Patent Number : 9492445

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21964

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2029-09-30

blank